First Tracks Biotherapeutics Inc share price logo

First Tracks Biotherapeutics Inc

NASDAQ: TRAX

Small Cap

$40.46

-2.05

(-4.82%)

as on

First Tracks Biotherapeutics Inc Stock Performance

as on September 5, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $40.45
    $42.00
    downward going graph

    0.02%

    Downside

    3.81%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

First Tracks Biotherapeutics Inc share price movements today

Previous Close
$42.51
Open
$41.06
Volume
531.0K
Market Cap
$1.6B
Day's Low - High
$40.45 - $42.00

First Tracks Biotherapeutics Inc Historical Returns

1 Month Return
-7.61 %
3 Month Return
+ 133.57 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

First Tracks Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check First Tracks Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

-2.39

Dividend Yield

0.00%

PE Ratio (TTM)

-17.79

Industry PE ratio

-6.69

PEG Ratio

-0.1778661087866109

Return On Equity TTM

-39.35%

First Tracks Biotherapeutics Inc Stock Valuation

Track how First Tracks Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

First Tracks Biotherapeutics Inc in the last 3 years

  • Overview

  • Trends

Lowest (-6.22x)

December 31, 2023

Industry (-6.69x)

December 31, 2025

Today (-3.98x)

December 31, 2025

Highest (-7.49x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -3.98x

First Tracks Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of First Tracks Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$1.6BNA-17.790.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$141.1B181.73%32.2186.04%NA
BUY$60.2B-64.27%-18.66-12.57%NA
BUY$84.8B24.12%20.1484.86%0.44%

Analyst Recommendation on First Tracks Biotherapeutics Inc Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for First Tracks Biotherapeutics Inc. Average target price of $67.43

Indian Investors' Interest in First Tracks Biotherapeutics Inc Stock

Search interest for First Tracks Biotherapeutics Inc Stock has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-73% versus previous 30 day period

First Tracks Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
Gross Profit
-
-
0
Operating Income
-51
-52
-34
EBITDA
-50
-52
-34
Interest Expense
-
-
-
Depreciation
0
0
0
Income Before Tax
-47
-50
-33
Income Tax Expense
-
-
-
Net Income
-47
-50
-33
Net Profit Margin
0.00%
0.00%
0.00%

First Tracks Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
Gross Profit
-
-152
-139
Operating Income
-118
-181
-179
EBITDA
-116
-178
-178
Interest Expense
-
-
-
Depreciation
2
2
0
Income Before Tax
-106
-163
-166
Income Tax Expense
-
-
-
Net Income
-106
-163
-166
Net Profit Margin
0.00%
0.00%
0.00%

First Tracks Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2025
Mar 2026
Jun 2026
Net Income
-47
-50
-33
Operating Cash Flow
-45
-32
-31
Investing Cash Flow
14
34
0
Financing Cash Flow
5
7
-48
Change in Cash
-24
10
-80

First Tracks Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-106
-163
-166
Operating Cash Flow
-93
-125
-142
Investing Cash Flow
144
95
228
Financing Cash Flow
-87
117
30
Change in Cash
-35
87
115

Mutual Funds that own First Tracks Biotherapeutics Inc Stock

Check out the Mutual Funds with significant holdings in First Tracks Biotherapeutics Inc.

Funds
Holdings
Shares Held
TIAA-CREF Funds
0.952711%
340412
Federated Hermes Equity Funds
0.811623%
290000
Fidelity Salem Street Trust
0.666939%
238303
Victory Portfolios III
0.624029%
222971
Fidelity Concord Street Trust
0.440616%
157436

Global Institutional Holdings in First Tracks Biotherapeutics Inc

Funds
Holdings
Vanguard
4.62%
SPDR
3.06%
iShares
2.91%
Michael Rockefeller
2.57%
Schwab
0.41%

Insights on First Tracks Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, TRAX stock has moved up by 143.7%

About First Tracks Biotherapeutics Inc

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a novel anti-CD122 antagonist that targets the shared beta subunit of the IL-15 and IL-2 receptors; Rosnilimab, a antibody engineered to selectively deplete pathogenic T cells in both the periphery and inflamed tissues; and ANB101, a BDCA2-modulating antibody designed to specifically target plasmacytoid dendritic cells (pDCs). First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was founded in 2019 and is based in San Diego, California.
OrganisationFirst Tracks Biotherapeutics Inc
Headquarters10770 Wateridge Circle, San Diego, CA, United States, 92121
IndustryBiotechnology
CEOMr. Daniel R. Faga
E-voting on sharesClick here to vote

Key Management of First Tracks Biotherapeutics Inc

Name

Title

Mr. Daniel R. Faga

CEO, President & Director

Dr. Paul F. Lizzul M.D.

Chief Medical Officer

Mr. Ajim A. Tamboli C.F.A.

Chief Financial Officer

Mr. Benjamin Stone

Chief Business Officer

Mr. Eric J. Loumeau

Secretary

FAQs

What is First Tracks Biotherapeutics Inc share price today?

First Tracks Biotherapeutics Inc share price today is $40.46 as on at the close of the market. First Tracks Biotherapeutics Inc share today touched a day high of $42.00 and a low of $40.45.

What is the 52 week high and 52 week low for First Tracks Biotherapeutics Inc share?

First Tracks Biotherapeutics Inc share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . First Tracks Biotherapeutics Inc stock price today i.e. is closed at $40.46,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is First Tracks Biotherapeutics Inc's market capitalisation today?

First Tracks Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in First Tracks Biotherapeutics Inc Stock (TRAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for First Tracks Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in First Tracks Biotherapeutics Inc Shares that will get you 0.0371 shares as per First Tracks Biotherapeutics Inc share price of $40.46 per share as on September 5, 2026 at 8:45 am IST.

What is the minimum amount required to buy First Tracks Biotherapeutics Inc Stock (TRAX) from India?

Indian investors can start investing in First Tracks Biotherapeutics Inc (TRAX) shares with as little as ₹94.49 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.90 in First Tracks Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on First Tracks Biotherapeutics Inc share’s latest price of $40.46 as on September 5, 2026 at 8:45 am IST, you will get 0.2472 shares of First Tracks Biotherapeutics Inc. Learn more about fractional shares .